HBI Deals+Insights / M&A/IPOs

Medicover’s M&A blitz strategy

Having IPOed in the summer of 2017, outpatient, lab and occupational healthcare group Medicover has no debt and a war chest for M&A. So what are its plans, and what has it learnt from recent deals? We catch up with CEO Fredrik Ragmark at the Jefferies Conference in London. He talks about Medicover's four main target markets - Germany, Ukraine, India and Poland.

We would welcome your thoughts on this story. Email your views to Max Hotopf or call 0207 183 3779.